Published 1 day ago • loading... • Updated 1 day ago

JPMorgan's top biopharma picks for 2025

Summary by CNBC

The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.

1 Articles

All

Left

Center

Right

The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated1 day agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States 1 day ago on Thursday, February 20, 2025.

Sources are mostly out of (0)